Implementation of Chlorhexidine Gluconate wash for preoperative patients would start on March 2018. Having the support of my clinical manager, we would review the cost-benefit analysis to ensure that this intervention is cost effective. In the next staff meeting February 2018, the nurses will be educated on the evidence base practiced for preventing SSI with the use of CHG. Engaging the nurses with questions or concerns regarding the benefits of implementing of CHG. Next this presentation would be given to key stakeholders in February 2018 and education of the staff would occur in the same month. This would give adequate time to overcome any obstacles in the implementation of CHG. A7. Identification of Stakeholders and/or partners
The primary key stakeholders for the implementation of Chlorhexidine Gluconate are; surgical service director, clinical manager, hospital material manager, nursing staff, electronic medical (EMR) manager, CHG vendor, and the patients. A7a. Importance of Key Stakeholders and/or partners
Each one of these stakeholders is essential components in implementing CHG and preventing surgical site infections. The director of the surgical floor will allocate funds to facilitate the CHG implementation. The hospital material …show more content…
Meeting with the individual stakeholder every month for the duration of the trail. Keeping the director of the surgical floor up to date with any obstacles and successes of this intervention. Providing feedback from the patients and the staff. Actively communicating with the hospital material manager to make sure that there are no problems supplying the CHG. Reinforcing the nursing staff hard work, maintaining open dialog with them, and addressing any concerns they have. Confirm that the nurses are educating the patients properly on the use of CHG, to make sure that the majority of the patients use the